Medi Assist Healthcare Services Earnings Call: Key Takeaways
Medi Assist reported FY26 operating income of ₹904.8Cr (25.1% YoY growth) and EBITDA of ₹174.6Cr (19.3% margin). The company became debt-free in January 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
46 announcements with these filters
Medi Assist reported FY26 operating income of ₹904.8Cr (25.1% YoY growth) and EBITDA of ₹174.6Cr (19.3% margin). The company became debt-free in January 2026.
Medi Assist delivered a strong FY26 with 23.6% revenue growth, reaching a ₹25,000 crore premium-under-management milestone. Management is pivoting toward AI-led 'borderless healthcare administration' and international expansion while maintaining debt-free status.
Medi Assist reported strong FY26 performance with 25.1% revenue growth and achieved debt-free status. Strategy focuses on AI-led platform transformation and international expansion into Southeast Asia.
Medi Assist reported FY26 operating revenue of ₹904.8 Crore, achieving 25.1% growth. The company became debt-free, driven by strong growth in its AI-led healthcare claims platform.
Medi Assist Healthcare Services recommended a final dividend of ₹2 per equity share for FY 2025-26. The payout remains subject to shareholder approval at the general meeting.
Medi Assist Healthcare Services submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms compliance with SEBI regulatory requirements.
Medi Assist Healthcare Services reported zero deviation in utilizing ₹198.00 Crore raised via preferential issue. Funds were deployed for subsidiary debt repayment and corporate purposes.
Medi Assist appointed PricewaterhouseCoopers Services LLP as Internal Auditors for financial year 2026-2027. The appointment follows Audit Committee recommendations to strengthen corporate governance.
Medi Assist designated Vinaya Natarajan, Praveen Samariya, and Dhruv Rastogi as Senior Managerial Personnel. These appointments strengthen the group's legal, technology, and AI leadership teams.
Medi Assist Healthcare Services Ltd reported revenue from operations of ₹242 Cr (+28.1% YoY) and net profit of ₹54.5 Cr (+152.3% YoY) for Q4 FY26.
Medi Assist reported annual consolidated total income of ₹923.24 Crore and recommended a ₹2 final dividend. These results demonstrate significant year-on-year revenue growth.
Medi Assist Healthcare Services Ltd has scheduled a Board Meeting on May 09, 2026, to approve FY26 audited financial results and consider a final dividend. An earnings call is also scheduled for May 11, 2026. The company's trading window remains closed until 48 hours after the results declaration.
Massachusetts Institute of Technology and 238 Plan Associates LLC acquired 50,000 shares of Medi Assist Healthcare Services Limited on April 29, 2026. This acquisition increased their cumulative holding to 5.02%, crossing the 5% regulatory threshold. The transaction was conducted via open market purchase.
Medi Assist Healthcare Services Limited announced that shareholders approved the appointment of Ms. Sunita Rebecca Cherian as a Non-Executive, Non-Independent Director via postal ballot. The resolution passed with 99.4555% majority. Voting concluded on April 26, 2026, and results were certified by Scrutinizer M/s. BMP & Co. LLP.
Medi Assist Healthcare Services approved the allotment of 92,415 equity shares following the exercise of options under its ESOP 2013 scheme. Consequently, the company's paid-up share capital increased to Rs. 37.35 Crore. The new shares rank pari-passu with existing equity.
Medi Assist Healthcare Services Limited allotted 92,415 equity shares on April 3, 2026, following the exercise of Employee Stock Options (ESOP). This allotment increases the company's paid-up share capital from ₹37.30 Crore to ₹37.35 Crore.